ATT Chart by TradingView

Business Description

Abattis Bioceuticals Corp. (“Abattis”) is an integrated cannabis company with a portfolio of assets focused on downstream services in the legal cannabis space.


FRC Analyst's Reports

Abattis Bioceuticals Corp. (CSE: ATT; OTC: ATTBF) – Suspending Coverage Jan. 11, 2019
Abattis Bioceuticals (CSE: ATT) Initiating; Integrated Downstream Cannabis Focused Aug. 22, 2018


Abattis Provides Update on Trading Halt and Corporate Developments Nov. 8, 2019
Abattis Completes Year End Audit and Provides Corporate Update Aug. 9, 2019
Abattis Announces Successful Closing of Pro Natura Acquisition May. 21, 2019
Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates Apr. 2, 2019
Abattis Announces Resignation of Directors Mar. 9, 2019

Investors are also interested in these companies: